Literature DB >> 25323158

Can the assessment of ABCB1 gene expression predict its function in vitro?

Petr Kosztyu1, Petr Dolezel1,2, Radka Vaclavikova3, Petr Mlejnek1.   

Abstract

Increased expression of the ABCB1 gene in cancer cells is usually connected with occurrence of multidrug resistance (MDR) and poor prognosis. However, the correlation between ABCB1 expression and MDR phenotype is difficult to prove in clinical samples. Most of the researchers believe that these difficulties are due to the poor reliability and sensitivity of assays for detection of ABCB1 expression in clinical samples. However, the complexity of P-gp mediated resistance cannot be reduced to the methodical difficulties only. Here, we addressed the question how widely used methods for detection of ABCB1 expression levels could predict its functional activity and thus its contribution to drug resistance in defined conditions in vitro. The ABCB1 expression was assessed at the mRNA level by quantitative real-time polymerase chain reaction (qRT-PCR), and at the protein level by flow cytometry using UIC2 antibody. The ABCB1 function was monitored using a calcein AM accumulation assay. We observed that K562 cells have approximately 320 times higher level of ABCB1 mRNA than HL-60 cells without detectable function. In addition, resistant K562/Dox cells exhibited significantly higher ABCB1 mRNA expression than resistant K562/HHT cells. However, the functional tests clearly indicated opposite results. Flow cytometric assessment of P-gp, although suggested as a reliable method, contradicted the functional test in K562/Dox and K562/HHT cells. We further used a set of MDR cells expressing various levels of P-gp. Similarly here, flow cytometry not always corresponded to the functional analysis. Our results strongly suggest that an approach which exclusively relies on a simple correlation between ABCB1 expression, either at the mRNA level or protein level, and overall resistance may fail to predict actual contribution of P-gp to overall resistance as the data indicating transporter expression reflect its function only roughly even in well-defined in vitro conditions.
© 2014 The Authors. European Journal of Haematology Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  P-glycoprotein; UIC2 antibody; correlation between ABCB1 expression and function; drug resistance; mRNA level of ABCB1; protein level of ABCB1; transporter expression; transporter function

Mesh:

Substances:

Year:  2015        PMID: 25323158     DOI: 10.1111/ejh.12470

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity.

Authors:  Jean-Marie Nicolas; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2019-05-28       Impact factor: 4.009

2.  Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation.

Authors:  Agnieszka Krawczenko; Aleksandra Bielawska-Pohl; Karolina Wojtowicz; Roksana Jura; Maria Paprocka; Elżbieta Wojdat; Urszula Kozłowska; Aleksandra Klimczak; Catherine Grillon; Claudine Kieda; Danuta Duś
Journal:  PLoS One       Date:  2017-02-17       Impact factor: 3.240

3.  Heat Shock Protein Inhibitor 17-Allyamino-17-Demethoxygeldanamycin, a Potent Inductor of Apoptosis in Human Glioma Tumor Cell Lines, Is a Weak Substrate for ABCB1 and ABCG2 Transporters.

Authors:  Nikola Pastvova; Petr Dolezel; Petr Mlejnek
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-29

4.  P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma.

Authors:  Valéria Dékay; Edina Karai; András Füredi; Kornélia Szebényi; Gergely Szakács; Péter Vajdovich
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

5.  Generation and characterization of iPSC-derived renal proximal tubule-like cells with extended stability.

Authors:  Vidya Chandrasekaran; Giada Carta; Daniel da Costa Pereira; Rajinder Gupta; Cormac Murphy; Elisabeth Feifel; Georg Kern; Judith Lechner; Anna Lina Cavallo; Shailesh Gupta; Florian Caiment; Jos C S Kleinjans; Gerhard Gstraunthaler; Paul Jennings; Anja Wilmes
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.